Callan is a graduate student in Molecular Biology under the Rutgers-Princeton M.D./Ph.D. program. Before coming to Princeton, Callan's research involved work in psychiatric epigenomics at Mount Sinai and Yale with a focus on cell type-specific chromatin remodeling in schizophrenia. They are broadly interested in investigating cerebellar contributions to learning and neurodevelopmental disorders.